Trailing-twelve-month (TTM) revenue is $27.78 Million with a year-over-year growth of +70.24%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q1 FY2026Period ended 2025-09-30 | $10,788,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12 |
| Q2 FY2026Period ended 2025-12-31 | $3,011,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-04 |
| Q3 FY2026Period ended 2026-03-31 | $3,418,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q4 FY2026Period ended 2026-06-30 | $10,559,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-26 |
| TTM revenue | $27,776,000 |
Current P/S: $67,731,137 market capitalization ÷ $27,776,000 TTM revenue = 2.44x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T13:52:38.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q4 FY2026 (2026-06-30): $10.56M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:21:57.782Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-06-30 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-06-30 · USD | FY20222022-06-30 · USD | FY20232023-06-30 · USD | FY20242024-06-30 · USD | FY20252025-06-30 · USD |
|---|---|---|---|---|---|
| Administration and Service Fees | N/A | $5M | $1M | $1M | $2M |
| Durable Medical Equipment Segment | $58M | N/A | N/A | N/A |
$27.78M
$27.78 Million
+70.24%
vs. $16.32M a year ago (TTM)
(14.52%)
5 Year compound annual growth rate
1 Year
+70.24%
3 Year
+47.44%
5 Year
(14.52%)
10 Year
N/A
15 Year
(10.85%)
20 Year
(12.61%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $27.78M | +$11.46M | +70.24% |
| 2025 | $16.32M | ($1.52M) | (8.51%) |
| 2024 | $17.83M | +$9.17M | +105.86% |
| 2023 | $8.66M | +$4.15M | +91.83% |
| 2022 | $4.52M | ($56.34M) | (92.58%) |
| 2021 |
TTM Growth
+70.24%
3-Year CAGR
+47.44%
5-Year CAGR
(14.52%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:21:57.782Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| General Corporate | $579,000 | N/A | N/A | N/A | N/A |
|---|
| Investment Management Segment | $3M | N/A | N/A | N/A | N/A |
|---|
| Management Service, Base | N/A | N/A | $6M | $9M | $11M |
|---|
| Project Management Fees | N/A | N/A | N/A | $75,000 | $941,000 |
|---|
| Property Management Fees | N/A | N/A | $1M | $1M | $1M |
|---|
| Real Estate Property Sales | N/A | N/A | N/A | $7M | $1M |
|---|
| Real Estate Rental Income | N/A | N/A | N/A | N/A | $317,000 |
|---|
| $60.85M |
| +$1.86M |
| +3.15% |
| 2020 | $58.99M | +$7.81M | +15.27% |
| 2019 | $51.18M | +$45.24M | +762.34% |
| 2018 | $5.93M | +$1.01M | +20.46% |
| 2017 | $4.93M | +$422,000 | +9.37% |
